Valtoco

Product manufactured by Neurelis, Inc

Application Nr Approved Date Route Status External Links
NDA211635 None Nasal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Valtoco ® Is Indicated For The Acute Treatment Of Intermittent, Stereotypic Episodes Of Frequent Seizure Activity (I.e., Seizure Clusters, Acute Repetitive Seizures) That Are Distinct From A Patient's Usual Seizure Pattern In Patients With Epilepsy 6 Years Of Age And Older. Valtoco Is A Benzodiazepine Indicated For The Acute Treatment Of Intermittent, Stereotypic Episodes Of Frequent Seizure Activity (I.e., Seizure Clusters, Acute Repetitive Seizures) That Are Distinct From A Patient's Usual Seizure Pattern In Patients With Epilepsy 6 Years Of Age And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Diazepam DIAZEPAM ZINC6427

Comments